The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Srinivasan Chari
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has received a disclosure under Regulation 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers Regulations, 2011, from Sunil Srinivasan Chari, who is a promoter of Rossari Biotech. This regulation requires promoters and persons acting in concert to disclose any acquisition or disposal of shares that results in a change of 2% or more of the company's share capital, or when crossing certain shareholding thresholds. The filing is a regulatory compliance update, though the specific direction (buy or sell) and quantum of the transaction have not been disclosed in the headline itself.
This is a routine regulatory disclosure indicating a change in promoter shareholding, which investors should monitor for any shift in promoter confidence or stake restructuring. The lack of transaction details in this filing means investors should look for the full disclosure document to understand the exact nature of the change and its potential implications for promoter holding levels.